Perigon Wealth Management, LLC Organon & Co. Transaction History

Perigon Wealth Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 29, 2024	BUY	$13.78 - $18.8 $141,796 - $193,452	10,290 New	10,290 $193,000
Q4 2022 Feb 14, 2023	BUY	$23.31 - $28.61 $181,911 - $223,272	7,804 New	7,804 $218,000
Q2 2022 Aug 11, 2022	BUY	$31.66 - $38.9 $12,189 - $14,976	385 Added 5.85%	6,962 $235,000
Q1 2022 May 16, 2022	BUY	$30.45 - $39.36 $200,269 - $258,870	6,577 New	6,577 $230,000
Q4 2021 Feb 11, 2022	SELL	$28.67 - $37.13 $187,186 - $242,421	-6,529 Closed	0 $0
Q3 2021 Nov 01, 2021	BUY	$28.63 - $35.64 $186,925 - $232,693	6,529 New	6,529 $214,000
Q3 2021 Oct 25, 2021	SELL	$28.63 - $35.64 $190,675 - $237,362	-6,660 Closed	0 $0
Q2 2021 Jul 19, 2021	BUY	$28.45 - $38.0 $189,477 - $253,080	6,660 New	6,660 $202,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.75B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Perigon Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Perigon Wealth Management, LLC with notifications on news.